Sentinel Node Biopsy:A Multimedia Patient Guide

描述(申请人提供)：Healthmark多媒体计划第一阶段 用于多媒体教育和决策支持的SBIR-为考虑 SNB治疗乳腺癌、黑色素瘤和其他可能发生的癌症 诊断程序。最初提出作为恶性疾病的诊断工具 黑色素瘤，瑞士央行正在接受乳腺癌和其他癌症。 对于那些考虑瑞士央行的人来说，几乎没有耐心的教育材料。这 产品将专注于手术过程、解剖学和生理学 技术、生存数据以及禁忌症。在第一阶段，我们将 为乳腺癌SNB开发患者信息。一种功能有限的原型 将在符合瑞士央行资格的乳腺癌妇女中进行测试。原型试验 结果将用于微调第二阶段的内容和方法。 第二阶段，该产品将扩大到包括关于 SNB用于其他癌症(如头颈部、胃肠道、泌尿系统和皮肤)。 完成后，互动指南在帮助癌症方面的有效性 患者比较他们的活检方案，检查风险和好处，讨论它们 与他们的医生一起做出决定将是决定性的。最后阶段 II产品将作为与Anne Arundel医院的合资企业进行货币化。 建议的商业应用： 目前还没有针对考虑前哨淋巴结活检的患者的多媒体教育。随着这一程序变得越来越广泛，并用于各种癌症，这种产品将引起在美国各地医院和癌症诊所执业的内科医生和外科医生的兴趣。

DESCRIPTION (provided by applicant): HealthMark Multimedia proposes a Phase I SBIR for a multimedia education and decision-support for patients considering a SNB for breast cancer, melanoma, and other cancers where this is a possible diagnostic procedure. Initially proposed as a diagnostic tool for malignant melanoma, the SNB is gaining acceptance for breast cancer and other cancers. There are few patient education materials for those considering a SNB. This product will focus on the procedure, anatomy and physiology behind the techniques, survival data as well as contraindications. In Phase I, we will develop patient information for breast cancer SNB. A limited function prototype will be tested with women with breast cancer eligible for SNB. Prototype test results will be used to fine-tune the content and approach for Phase II. In Phase II, the product will be expanded to include information on the role of SNB for other cancers (e.g. head & neck, gastrointestinal, urologic and skin). After completion, effectiveness of the interactive guide in helping cancer patients compare their biopsy options, examine risks and benefits, discuss them with their physician and come to a decision will be determined. The final Phase II product will be monetized as a joint venture with Anne Arundel Hospital. PROPOSED COMMERCIAL APPLICATIONS: There is currently no multimedia education for patients considering a sentinel node biopsy. As the procedure becomes more widespread and used for a variety of cancers, this product will be of interest to physicians and surgeons practicing in hospitals and cancer clinics throughout the US.